Solvay Pharma AG Company Profile

17:46 EDT 20th March 2018 | BioPortfolio



Untermattweg 8
CH - 3027


Phone: 41 31 996 96 00
Fax: 41 31 996 96 99

News Articles [597 Associated News Articles listed on BioPortfolio]

Solvay Hikes German Sodium Bicarbonate Output

Solvay will invest €6 million at its site in Rheinberg, Germany, to expand sodium bicarbonate capacity. Startup is planned by the end of 2018. Actual capacity figures were not disclosed.

Solvay and Vietnam’s PVCFC in Fertilizer Deal

Solvay is giving PetroVietnam Camau Fertilizer Company (PVCFC) exclusive access to its proprietary AgRho N-Dual Protect nitrogen stabilizer under a four-year supply deal. Financial terms of the contra...

Lanxess Completes Solvay Additives Buy

Following the approval of all regulatory instances, German specialty chemicals producer Lanxess has successfully completed its acquisition of Solvay’s €65 million phosphorus chemicals busin...

Lanxess to Buy Solvay's US Phosphorus Additives Business

In a move to expand its additives portfolio, Germany’s Lanxess has clinched a deal with Solvay to acquire the Belgian chemical producer’s US phosphorus chemicals business based at Charlest...

Solvay sells Spanish Chlorine Plant to CUF

Solvay is selling its chloralkali plant at Torrelavega, Spain, to Portuguese producer CUF for an undisclosed sum. CUF said it intends to invest €55 million to acquire the plant and install a memb...

NASDAQ OMX Nordic: Derivatives: Anticipated adjustment in Karo Pharma due to rights issue (24/17)

The following information is based on a press release from Karo Pharma AB (Karo Pharma) published on December 5, 2017 and may be subject to change. The board of Karo Pharma has proposed that the Ex...

Verona Pharma plc: Verona Pharma to Announce Operational Update and Financial Results for Full Year ended December 31, 2017

LONDON, Feb. 22, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ('Verona Pharma'), a clinical-stage biopharmaceutical company focused on developing and commercializing innovati...

Verona Pharma plc: Verona Pharma Reports Operational Update and Financial Results for Full Year Ended December 31, 2017

LONDON, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) (Verona Pharma), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative...

Drugs and Medications [239 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [25 Associated PubMed Articles listed on BioPortfolio]

Delivering advanced therapies: The big pharma approach.

After two decades of focused development and some recent clinical successes, cell and gene therapy (CGT) is emerging as a promising approach to personalized medicines. Genetically engineered cells as ...

Bioanalytical outsourcing: transitioning from Pharma to CRO.

Peter J. Dunn Award / International Solvay Chair in Chemistry for Gernot Frenking / Max Born Prize for Angel Rubio / Terrae Rarae Prize for Rhett Kempe / Frontiers in Chemical Energy Science Award for Karsten Reuter / And also in the News.

Moving pharma contracting into the era of accountability.

A guide to manufacturing CAR T cell therapies.

In recent years, chimeric antigen receptor (CAR) modified T cells have been used as a treatment for haematological malignancies in several phase I and II trials and with Kymriah of Novartis and Yescar...

Clinical Trials [81 Associated Clinical Trials listed on BioPortfolio]

REFRAME RPD Post-Market Clinical Study

To evaluate the change in patient Oral Health-related Quality of Life (OHRQoL) from wearing a cobalt chrome (CoCr) removable partial denture (RPD) to wearing the Solvay Dental 360TM polyme...

Clinical Non-Inferiority of Pancreatic Enzymes (Norzyme ® - Bergamo) Compared To Creon ® (Solvay Pharmaceutical) in Patients With Exocrine Pancreatic Insufficiency

The primary objective of this clinical trial is to demonstrate non-inferiority clinical development of pancreatic enzymes from Laboratory Bergamo (Norzyme ®) in relation to pancreatic enz...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Companies [749 Associated Companies listed on BioPortfolio]


Fournier Pharma has been acquired by the Solvay Group in July 2005.Solvay is an international chemicals and pharmaceuticals group with headquarters in Brussels. It is present in more than 50 countries...

Solvay America,

North America plays an important and dynamic role in the activities of the Solvay Group, as the people of the Solvay America companies work together to maintain founder Ernest Solvay's commitment to c...


Solvay has not stopped expanding since it was founded in 1863. The time-line below gives an overview, in key stages, of its development from the beginning until today.Solvay Group began on 15 April 18...

Solvay Pharma AG


Solvay GmbH

Solvay Pharmaceuticals operates in two key therapeutic fields, in which it undertakes a full range of Research and Development activities: * Cardiometabolics (including the fenofibrate franch...

More Information about "Solvay Pharma AG" on BioPortfolio

We have published hundreds of Solvay Pharma AG news stories on BioPortfolio along with dozens of Solvay Pharma AG Clinical Trials and PubMed Articles about Solvay Pharma AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Solvay Pharma AG Companies in our database. You can also find out about relevant Solvay Pharma AG Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record